Fluoroscopy Mobile C-Arms Market Size

Fluoroscopy Mobile C-Arms Market Growth Projections and Opportunities

Fluoroscopy, a medical imaging technique, involves the use of multiple x-rays to produce real-time images or videos of a patient's internal structures. This method is commonly utilized in a variety of interventional radiological procedures, playing a crucial role in treating conditions such as spinal cord injury, varicose veins, peripheral artery disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other chronic ailments. The global fluoroscopy and mobile c-arms market is experiencing significant growth, driven by factors such as the increasing prevalence of chronic diseases, a growing aging population, and the expanding adoption of fluoroscopy in orthopedic and neurological procedures.

As of 2017, the global fluoroscopy and mobile c-arms market boasted a valuation of USD 2,234.3 million, with expectations to reach USD 2,951.4 million by 2023. The Americas held the largest market share in 2017, accounting for 44.7% with a value of USD 997.7 million, closely followed by Europe at USD 734.4 million.

The market has been segmented based on device type, application, and end user. In terms of device type, it is categorized into fluoroscopy systems and mobile c-arms. The fluoroscopy systems segment dominated the market, securing a value of USD 1,390.2 million in 2017.

The application-based segmentation includes gastrointestinal, orthopedics, cardiovascular, pain management and trauma, neurology, urology, and others. Among these, the gastrointestinal segment emerged as the largest in 2017, with a market value of USD 571.7 million.

Considering end-user categories, the market is divided into hospitals & clinics, diagnostic centers, research and academic institutes, and others. The hospitals & clinics segment led the market, reaching a value of USD 896.0 million in 2017.

The growth of the fluoroscopy and mobile c-arms market is intricately linked to the increasing incidence of chronic diseases worldwide. Chronic conditions, such as spinal cord injuries, cardiovascular diseases, and orthopedic ailments, necessitate precise and real-time imaging for accurate diagnosis and treatment planning. Fluoroscopy, with its ability to provide dynamic imaging, is becoming indispensable in these medical interventions.

One of the significant contributors to market growth is the expanding geriatric population. Elderly individuals often require intricate medical procedures and diagnostics, where fluoroscopy and mobile c-arms play a pivotal role. Additionally, as the global population ages, there is a surge in the prevalence of chronic diseases, further fueling the demand for these imaging techniques.

The adoption of fluoroscopy in orthopedic and neurological procedures is another driving factor. In orthopedics, real-time imaging is crucial for procedures like joint replacements, fracture reductions, and spine surgeries. Similarly, in neurology, fluoroscopy aids in intricate interventions such as spinal cord stimulator placements and neurovascular procedures.

On the geographical front, the Americas stand as a major market player, attributed to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. Europe, too, holds a substantial market share, driven by technological advancements and a proactive approach to adopting innovative medical solutions.